Parametric Portfolio Associates’s ChemoCentryx CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
Parametric Portfolio Associates's CCXI Position: Q1 2022 in Review
Parametric Portfolio Associates reduced its ChemoCentryx (CCXI) stake by 8.7% in Q1 2022, selling an estimated $651K and leaving 243,610 shares worth $6.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1715.
Parametric Portfolio Associates first reported a position in CCXI in Q4 2013 and has held it in 24 quarters since. The position peaked at $9.7M in Q4 2021. 176 funds tracked by Wall St. Rank hold CCXI as of Q1 2022.
- Parametric Portfolio Associates held 243,610 shares of ChemoCentryx worth $6.11M as of Q1 2022.
- Parametric Portfolio Associates sold 23,150 ChemoCentryx shares in Q1 2022, an estimated $651K.
- ChemoCentryx made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1715 holding.
- Parametric Portfolio Associates first reported a position in ChemoCentryx in Q4 2013 and has held it in 24 quarters since.
- Parametric Portfolio Associates's ChemoCentryx position peaked at $9.7M in Q4 2021.
- 176 funds tracked by Wall St. Rank held ChemoCentryx as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.